Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Raw Materials (2016 - 2025)

Orthofix Medical's Raw Materials history spans 15 years, with the latest figure at $22.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials fell 15.88% year-over-year to $22.9 million, compared with a TTM value of $22.9 million through Dec 2025, down 15.88%, and an annual FY2025 reading of $22.9 million, down 15.88% over the prior year.
  • Raw Materials for Q4 2025 was $22.9 million at Orthofix Medical, down from $24.8 million in the prior quarter.
  • The five-year high for Raw Materials was $30.9 million in Q1 2024, with the low at $8.0 million in Q3 2021.
  • Average Raw Materials over 5 years is $21.0 million, with a median of $24.0 million recorded in 2023.
  • Year-over-year, Raw Materials skyrocketed 119.11% in 2022 and then fell 15.88% in 2025.
  • Tracing OFIX's Raw Materials over 5 years: stood at $9.6 million in 2021, then skyrocketed by 77.65% to $17.0 million in 2022, then surged by 66.66% to $28.4 million in 2023, then decreased by 4.26% to $27.2 million in 2024, then fell by 15.88% to $22.9 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Raw Materials are $22.9 million (Q4 2025), $24.8 million (Q3 2025), and $26.6 million (Q2 2025).